Mitochondrial Metabolism in Alveolar Macrophages of Patients Infected with HIV, Tuberculosis, and HIV/Tuberculosis

AIDS Res Hum Retroviruses. 2024 Mar;40(3):148-157. doi: 10.1089/AID.2023.0064. Epub 2023 Nov 14.

Abstract

Tuberculosis (TB) is one of the most common opportunistic infections and is a leading cause of mortality in patients with HIV and AIDS. HIV infection causes serious defects in the host immune system and increases the risk of active TB. TB infection promotes HIV replication and aggravates host damage in patients with HIV/AIDS. Alveolar macrophages (AMs) are essential immune cells during TB and HIV infections. AMs undergo a shift in mitochondrial metabolism during TB or HIV infection, that is, metabolic reprogramming, allowing them to act in the form of classical activated macrophages (M1) and alternative activated macrophages (M2) at different stages of infection. We reviewed the alterations in the mitochondrial energy metabolism of AMs in patients with HIV, TB, and HIV/TB to provide ideas for further research on the role of metabolic reprogramming by AMs in the pathogeneses of HIV, TB, and HIV/TB coinfection.

Keywords: HIV; alveolar macrophages; metabolic reprogramming; mitochondrial; tuberculosis.

Publication types

  • Review

MeSH terms

  • Coinfection*
  • HIV Infections* / complications
  • HIV Infections* / metabolism
  • Humans
  • Macrophages
  • Macrophages, Alveolar
  • Mycobacterium tuberculosis*
  • Tuberculosis* / complications